GregoryAramSahagianMD

Neurology • Carlsbad, CA

Neuromuscular Medicine

CEO

Join to view full profile

Dr. Sahagian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sahagian's full profile

Already have an account?

Office
6010 Hidden Valley Rd
Ste 200
Carlsbad, CA 92011
Phone+1 760-631-3000

Fax+1 760-631-3016

Summary

Dr. Gregory Sahagian is a neurologist in Carlsbad, CA and is affiliated with multiple hospitals in the area, including Scripps Memorial Hospital-La Jolla, Tri-City Medical Center, Palomar Medical Center Escondido, Scripps Memorial Hospital-Encinitas, and Rady Children's Hospital - San Diego. He received his medical degree from Albert Einstein College of Medicine and has been in practice 24 years. He specializes in neuromuscular medicine and is experienced in nerve conduction studies, electromyography, neurology, health technology/informatics, and healthcare quality.

Education & Training

University of California (San Diego) Medical CenterFellowship, Neuromuscular Medicine (Neurology), 1999 - 2000
University of California (San Diego) Medical CenterChief Residency, Neurology, 1998 - 1999
University of California (San Diego) Medical CenterResidency, Neurology, 1996 - 1999
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 1995 - 1996
Albert Einstein College of MedicineClass of 1995, MD
Columbia UniversityBS, Chemical Engineering, 1987 - 1991

Certifications & Licensure

CA State Medical License 1997 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine

Awards, Honors, & Recognition

The Joint Commission Gold Seal National Quality Approval The Joint Commsission
Gold Medal The Joint Commission
San Diego Top Doc San Diego County Medical Society, 2007, 2013-2015, 2017-2018, 2020
AANEM Accredited Lab with Exemplary Status AANEM, 2013
Join now to see all

Clinical Trials

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Start of enrollment: 2016 Feb 11
Completed
Phase 3
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia Start of enrollment: 2016 Jul 01
Terminated
Phase 3
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine Start of enrollment: 2016 Jul 22
Completed
Phase 3
A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness. Start of enrollment: 2019 Mar 01
Completed
Phase 3
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients Start of enrollment: 2019 May 21
Completed
Phase 2
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) Start of enrollment: 2019 Apr 22
Completed
Phase 2
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Start of enrollment: 2019 Sep 30
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) Start of enrollment: 2020 Sep 18
ACTIVE_NOT_RECRUITING
PHASE2
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) Start of enrollment: 2020 Apr 15
COMPLETED
PHASE2
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Start of enrollment: 2020 Jun 19
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2020 Nov 26
ACTIVE_NOT_RECRUITING
PHASE3
Synuclein-One Study Start of enrollment: 2021 Jan 04
Completed
Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis Start of enrollment: 2021 Feb 05
Completed
Phase 3
Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention Start of enrollment: 2021 Apr 13
Completed
Not Applicable
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) Start of enrollment: 2019 Dec 04
Recruiting
Phase 2
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis Start of enrollment: 2021 Dec 16
ACTIVE_NOT_RECRUITING
PHASE3
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis Start of enrollment: 2022 Jun 27
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants with Early Alzheimer's Disease (ALTITUDE-AD) Start of enrollment: 2024 Feb 29
ACTIVE_NOT_RECRUITING
PHASE2
A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine Start of enrollment: 2019 Nov 07
Completed
Phase 3
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 18
TERMINATED
PHASE3
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) Start of enrollment: 2024 Nov 13
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

43 citations
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Christopher H Gibbons, Todd Levine, Charles Adler, Bailey Bellaire, Ningshan Wang
JAMA. 2024-04-16
Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.
Bruce Seligmann, Salvatore Camiolo, Monica Hernandez, Joanne M Yeakley, Gregory Sahagian
Journal of Alzheimer's Disease. 2024-01-01
6 citations
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.
Richard J Nowak, Ari Breiner, Vera Bril, Jeffrey A Allen, Shaida Khan
Annals of Clinical and Translational Neurology. 2024-01-01

Press Mentions

New Scripps Encinitas Physical Rehabilitation Center Empowers PatientsAugust 23rd, 2021
Scripps Health Opens Comprehensive Rehabilitation CenterJune 17th, 2021
Scripps Health Opens Comprehensive Rehabilitation Services Center in EncinitasJune 17th, 2021

Committees

Board Member, San Diego County Alzheimer's Project 2018 - Present
Board Member, Myasthenia Gravis Foundation of California Medical Advisory Board 2015 - Present
California State Liaison, American Association of Neuromuscular and Electrodiagnostic Medicine 2007 - Present
CMA delegate, Association of California Neurologists 2006 - 2009
AMA Young Physician Delegate, California Medical Association 2006 - 2009
Program Chairman, San Diego Neurology Society 2002 - 2004